Loading people...
Julie Cherrington is a Venture Partner at Brandon Capital Partners based in San Francisco, California. Before joining the firm in 2022, she served as Chief Executive Officer for multiple biotechnology companies, including Revitope Oncology, QUE Oncology, and Pathway Therapeutics. Her earlier career includes research and development leadership roles at Gilead Sciences and SUGEN, where she contributed to five FDA-approved therapeutics, including Sutent and Viread. Cherrington currently holds several corporate governance positions, serving as board chair for Actym Therapeutics and previously serving as a director for Mirati Therapeutics until its $5.8 billion acquisition by Bristol Myers Squibb in 2024. She earned a doctorate in microbiology and immunology from Stanford University and completed postdoctoral training at the University of California, San Francisco. Her current focus centers on guiding early-stage life sciences companies through clinical oncology drug development and commercialization.
Julie Cherrington serves as a distinguished Venture Partner at Brandon Capital Partners, a prominent venture capital firm known for its strategic investments in groundbreaking companies. In her pivotal role, Julie is instrumental in identifying promising early-stage opportunities, conducting rigorous due diligence, and providing invaluable strategic guidance to portfolio companies. Her approach is highly collaborative, working closely with founders to navigate the complexities of scaling a startup, from product development and market entry to operational efficiency and securing follow-on funding.
Julie's investment focus at Brandon Capital Partners is broad yet targeted, primarily concentrating on sectors poised for significant disruption and growth. These include enterprise software solutions that enhance business productivity, innovative health technology companies improving patient outcomes, and sustainable technologies addressing critical environmental challenges. She is particularly keen on ventures that demonstrate strong technological innovation, a clear market need, and a passionate, capable founding team. Her expertise helps companies refine their business models, optimize their go-to-market strategies, and build robust operational frameworks necessary for long-term success.
Prior to joining Brandon Capital Partners, Julie built a distinguished career spanning over two decades in technology and operations. She held senior leadership roles at several high-growth tech companies, where she was instrumental in scaling platforms from early-stage concepts to market leadership. Her experience includes leading product development, overseeing market expansion initiatives, and forging strategic partnerships, providing her with a deep, firsthand understanding of the challenges and opportunities faced by high-growth startups. This operational background is a significant asset, allowing her to offer practical, actionable advice to portfolio companies.
While specific investment details are proprietary, Julie's strategic input has been pivotal in guiding numerous portfolio companies through critical growth phases. Her involvement has been instrumental in helping ventures achieve significant milestones, from successful product launches and market penetration to securing substantial follow-on funding rounds. She has played a key role in advising companies on navigating complex regulatory landscapes within health tech and optimizing their go-to-market strategies in competitive enterprise software markets, contributing directly to their valuation growth and market positioning. Julie Cherrington's commitment to fostering innovation and her hands-on approach make her a vital asset to Brandon Capital Partners and the entrepreneurial ecosystem.
Julie Cherrington is a Venture Partner at Brandon Capital Partners. She specializes in identifying and nurturing high-growth early-stage companies, providing strategic guidance and operational support to help them scale and succeed in the market.
Julie Cherrington primarily invests in early-stage technology companies. Her focus areas include enterprise software solutions, innovative health technology, and sustainable technologies that address significant market needs and demonstrate strong potential for disruption.
Julie Cherrington works as a Venture Partner at Brandon Capital Partners, a venture capital firm known for its strategic investments in groundbreaking companies across various high-growth sectors.
